Viewing Study NCT06907056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2026-01-29 @ 9:40 PM
Study NCT ID: NCT06907056
Status: RECRUITING
Last Update Posted: 2025-04-04
First Post: 2025-03-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico
Sponsor: José Antonio Mata Marín
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV View
None dual therapy View
None DRV/c+3TC View
None effectiveness View
None non-inferiority View